Medline falls as backers slice stakes in $2.1 bln secondary offering

By Reuters News

** Medical-surgical supplies giant Medline's MDLN.O shares down 3.4% at $36.39 before the bell after ~$2.1 bln secondary offering priced

** MDLN late Weds announced sale of 60 mln shares by stockholders Blackstone BX.N, Carlyle Group CG.O, Hellman & Friedman (H&F), GIC Private and Abu Dhabi Investment Authority (ADIA) at $35.50

** Offering price represents 5.8% discount to stock's last sale of $37.68 on Tues

** MDLN shares closed at $39.47 on Fri; MDLN launched the offering early Mon

** Private equity sponsors BX and H&F selling ~19 mln shares each, CG offloading ~9.5 mln; GIC and ADIA offering ~9.3 mln ~3.1 mln shares, respectively, per the prospectus

** Also, MDLN agreed to repurchase $200 mln of shares and partnership interests from selling shareholders in private transaction

** Goldman Sachs, Morgan Stanley, BofA and JP Morgan leading public offering

** Through Tues, stock gained 17% in Nov, leaving it down ~10% YTD

** Northfield, Illinois-based MDLN went public last Dec in over $6 bln IPO priced at $29

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk